vs

Side-by-side financial comparison of ACCESS Newswire Inc. (ACCS) and Tonix Pharmaceuticals Holding Corp. (TNXP). Click either name above to swap in a different company.

ACCESS Newswire Inc. is the larger business by last-quarter revenue ($5.8M vs $5.4M, roughly 1.1× Tonix Pharmaceuticals Holding Corp.). ACCESS Newswire Inc. runs the higher net margin — -9.9% vs -870.3%, a 860.4% gap on every dollar of revenue. On growth, Tonix Pharmaceuticals Holding Corp. posted the faster year-over-year revenue change (108.8% vs -0.5%). Over the past eight quarters, Tonix Pharmaceuticals Holding Corp.'s revenue compounded faster (47.4% CAGR vs 2.0%).

PR Newswire is a distributor of press releases headquartered in Chicago. The service was created in 1954 to allow companies to electronically send press releases to news organizations, using teleprinters at first. The founder, Herbert Muschel, operated the service from his house in Manhattan for approximately 15 years. The business was eventually sold to Western Union and then United Newspapers of London. In December 2015, Cision Inc. announced it would acquire the company. On January 1, 2021...

Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.

ACCS vs TNXP — Head-to-Head

Bigger by revenue
ACCS
ACCS
1.1× larger
ACCS
$5.8M
$5.4M
TNXP
Growing faster (revenue YoY)
TNXP
TNXP
+109.2% gap
TNXP
108.8%
-0.5%
ACCS
Higher net margin
ACCS
ACCS
860.4% more per $
ACCS
-9.9%
-870.3%
TNXP
Faster 2-yr revenue CAGR
TNXP
TNXP
Annualised
TNXP
47.4%
2.0%
ACCS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACCS
ACCS
TNXP
TNXP
Revenue
$5.8M
$5.4M
Net Profit
$-576.0K
$-46.9M
Gross Margin
77.4%
80.4%
Operating Margin
-13.1%
-895.8%
Net Margin
-9.9%
-870.3%
Revenue YoY
-0.5%
108.8%
Net Profit YoY
94.4%
-112.2%
EPS (diluted)
$-0.16
$-4.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACCS
ACCS
TNXP
TNXP
Q4 25
$5.8M
$5.4M
Q3 25
$5.7M
$3.3M
Q2 25
$5.6M
$2.0M
Q1 25
$5.5M
$2.4M
Q4 24
$5.8M
$2.6M
Q3 24
$5.6M
$2.8M
Q2 24
$6.0M
$2.2M
Q1 24
$5.6M
$2.5M
Net Profit
ACCS
ACCS
TNXP
TNXP
Q4 25
$-576.0K
$-46.9M
Q3 25
$-45.0K
$-32.0M
Q2 25
$-475.0K
$-28.3M
Q1 25
$5.4M
$-16.8M
Q4 24
$-10.2M
$-22.1M
Q3 24
$-466.0K
$-14.2M
Q2 24
$7.0K
$-78.8M
Q1 24
$-139.0K
$-14.9M
Gross Margin
ACCS
ACCS
TNXP
TNXP
Q4 25
77.4%
80.4%
Q3 25
74.6%
58.4%
Q2 25
76.2%
-63.8%
Q1 25
78.0%
61.2%
Q4 24
75.2%
54.2%
Q3 24
75.0%
44.9%
Q2 24
77.2%
-52.5%
Q1 24
75.1%
33.1%
Operating Margin
ACCS
ACCS
TNXP
TNXP
Q4 25
-13.1%
-895.8%
Q3 25
-3.2%
-1005.1%
Q2 25
-4.4%
-1416.2%
Q1 25
-12.4%
-660.9%
Q4 24
-245.8%
-870.6%
Q3 24
-10.7%
-551.2%
Q2 24
-8.8%
-3501.6%
Q1 24
-15.5%
-860.2%
Net Margin
ACCS
ACCS
TNXP
TNXP
Q4 25
-9.9%
-870.3%
Q3 25
-0.8%
-972.9%
Q2 25
-8.5%
-1415.0%
Q1 25
98.4%
-692.8%
Q4 24
-175.0%
-856.2%
Q3 24
-8.3%
-503.6%
Q2 24
0.1%
-3567.8%
Q1 24
-2.5%
-601.9%
EPS (diluted)
ACCS
ACCS
TNXP
TNXP
Q4 25
$-0.16
$-4.28
Q3 25
$-0.01
$-3.59
Q2 25
$-0.12
$-3.86
Q1 25
$1.40
$-2.84
Q4 24
$-2.66
$2302.65
Q3 24
$-0.12
$-22.68
Q2 24
$0.00
$-1920.85
Q1 24
$-0.04
$-535.72

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACCS
ACCS
TNXP
TNXP
Cash + ST InvestmentsLiquidity on hand
$3.0M
$207.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$30.3M
$245.2M
Total Assets
$42.0M
$277.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACCS
ACCS
TNXP
TNXP
Q4 25
$3.0M
$207.6M
Q3 25
$3.3M
$190.1M
Q2 25
$125.3M
Q1 25
$131.7M
Q4 24
$4.1M
$98.8M
Q3 24
$28.2M
Q2 24
$4.2M
Q1 24
$7.0M
Total Debt
ACCS
ACCS
TNXP
TNXP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$8.7M
Q3 24
$9.4M
Q2 24
$10.1M
Q1 24
$10.8M
Stockholders' Equity
ACCS
ACCS
TNXP
TNXP
Q4 25
$30.3M
$245.2M
Q3 25
$30.8M
$231.1M
Q2 25
$30.7M
$168.0M
Q1 25
$30.9M
$180.4M
Q4 24
$25.2M
$139.6M
Q3 24
$35.3M
$74.2M
Q2 24
$35.4M
$42.1M
Q1 24
$35.2M
$108.1M
Total Assets
ACCS
ACCS
TNXP
TNXP
Q4 25
$42.0M
$277.2M
Q3 25
$44.0M
$252.4M
Q2 25
$45.6M
$187.4M
Q1 25
$47.3M
$192.9M
Q4 24
$50.6M
$162.9M
Q3 24
$61.7M
$95.0M
Q2 24
$62.8M
$70.3M
Q1 24
$64.4M
$135.3M
Debt / Equity
ACCS
ACCS
TNXP
TNXP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.06×
Q3 24
0.13×
Q2 24
0.24×
Q1 24
0.10×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACCS
ACCS
TNXP
TNXP
Operating Cash FlowLast quarter
$258.0K
$-39.6M
Free Cash FlowOCF − Capex
$-41.5M
FCF MarginFCF / Revenue
-770.4%
Capex IntensityCapex / Revenue
0.0%
34.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-103.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACCS
ACCS
TNXP
TNXP
Q4 25
$258.0K
$-39.6M
Q3 25
$-582.0K
$-28.8M
Q2 25
$135.0K
$-14.8M
Q1 25
$747.0K
$-16.6M
Q4 24
$866.0K
$-14.6M
Q3 24
$1.5M
$-18.8M
Q2 24
$-190.0K
$-9.9M
Q1 24
$986.0K
$-17.6M
Free Cash Flow
ACCS
ACCS
TNXP
TNXP
Q4 25
$-41.5M
Q3 25
$-590.0K
$-29.7M
Q2 25
$-15.4M
Q1 25
$735.0K
$-16.6M
Q4 24
$-14.6M
Q3 24
$1.5M
$-18.8M
Q2 24
Q1 24
$970.0K
$-17.7M
FCF Margin
ACCS
ACCS
TNXP
TNXP
Q4 25
-770.4%
Q3 25
-10.3%
-904.1%
Q2 25
-768.8%
Q1 25
13.4%
-682.8%
Q4 24
-566.7%
Q3 24
26.5%
-666.5%
Q2 24
Q1 24
17.4%
-712.4%
Capex Intensity
ACCS
ACCS
TNXP
TNXP
Q4 25
0.0%
34.8%
Q3 25
0.1%
29.2%
Q2 25
0.0%
26.4%
Q1 25
0.2%
0.2%
Q4 24
0.0%
0.1%
Q3 24
0.1%
0.3%
Q2 24
0.0%
0.0%
Q1 24
0.3%
4.4%
Cash Conversion
ACCS
ACCS
TNXP
TNXP
Q4 25
Q3 25
Q2 25
Q1 25
0.14×
Q4 24
Q3 24
Q2 24
-27.14×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACCS
ACCS

Cost To Deliver Products$3.1M54%
Employee Costs$1.7M29%
Other$1.0M17%

TNXP
TNXP

Zembrace Symtouch$3.1M58%
Other$2.3M42%

Related Comparisons